[ Akonni Biosystems raises $4M in Series D ]

Akonni Biosystems has raised $4 million in Series D funding.

Founded in 2003, Akonni Biosystems is preparing its first FDA submission for a clinical IVD pharmacogenomic test on the TruDx®2000 platform, utilizing its proprietary TruArray® 3D gel-drop microarray technology. In addition, the company plans to list its automated sample prep instrument with the FDA as a Class-I device. It is also accelerating development of its TruDx®3000.

The company will use the new money to continue to develop its platform.

Funding  Series D
Founded  2003
Country  USA
City  Frederick, Maryland
Founder / CEO  Charles Daitch
Deal Size  $4M
Investors   M.M. Dillon & Co.
Previous Investors  Argonne National Laboratory
 Maryland Venture Fund
 National Institutes of Health